dofomin 500mg tablet
imeks pharma sdn. bhd. - micronized purified flavonoidic fraction (diosmine 450mg & flavonoids expressed as hesperidine 50mg) -
symbicort turbuhaler 804.5 mcgdose
astrazeneca (israel) ltd - budesonide micronized; formoterol fumarate - powder for inhalation - budesonide micronized 80 mcg/dose; formoterol fumarate 4.5 mcg/dose - formoterol and budesonide - formoterol and other drugs for obstructive airway diseases - symbicort turbuhaler is indicated in the regular treatment of asthma where use of a combination (inhaled corticosteroid and long acting beta-agonist) is appropriate: - patients not adequaterly controlled with inhaled corticosteroids and " as needed" inhaled short acting beta2- agonists. - or patients already adequately controlled on both inhaled corticosteroids and long acting beta2- agonists. note: symbicort turbuhaler 80/4.5 mcg/dose is not appropriate in patients with severe asthma.
symbicort turbuhaler 1604.5 mcgdose
astrazeneca (israel) ltd - budesonide micronized; formoterol fumarate - powder for inhalation - budesonide micronized 160 mcg/dose; formoterol fumarate 4.5 mcg/dose - formoterol and budesonide - formoterol and other drugs for obstructive airway diseases - asthmasymbicort turbuhaler 160/4.5 mcg/dose is indicated in adults and adolescents (12 years and older), for the treatment of asthma, to achieve overall asthma control, including the relief of symptoms and the reduction of the risk of exacerbations.chronic obstructive pulmonary disease (copd)symbicort turbuhaler 160/4.5 mcg/dose is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev1) < 70% predicted normal (post-bronchodilator) and an exacerbation history despite regular bronchodilator therapy.
symbicort turbuhaler 3209 mcgdose
astrazeneca (israel) ltd - budesonide micronized; formoterol fumarate - powder for inhalation - budesonide micronized 320 mcg/dose; formoterol fumarate 9 mcg/dose - formoterol and budesonide - formoterol and other drugs for obstructive airway diseases - symbicort turbuhaler 320/9 mcg/dose is indicated in adults and adolescents, age 12 -17 for the regular treatment of asthma where use of a combination (inhaled corticosteroid and long acting β2 adrenoceptor-agonist) is appropriate:-patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short acting β2 adrenoceptor-agonists.or- patients already adequately controlled on both inhaled corticosteroids and long acting β2 adrenoceptoragonists.chronic obstructive pulmonary disease (copd)symbicort turbuhaler 320/9 mcg/dose is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with copd with forced expiratory volume in i second (fev1) < 70% predicted normal (post-bronchodilator) and an exacerbation history despite regular bronchodilator therapy
fenosaph-200 200 mg micronized capsule
n/a; importer: nelpa lifesciences, inc.; distributor: nelpa lifesciences, inc. - fenofibrate - micronized capsule - 200 mg
ryaltris nasal spray 60025mcg
lotus international pte. ltd. - mometasone furoate monohydrate (micronized) eqv to mometasone furoate; olopatadine hcl eqv to olopatadine - spray, suspension - mometasone furoate monohydrate (micronized) eqv to mometasone furoate 25 mcg/spray; olopatadine hcl eqv to olopatadine 600 mcg/spray
fenosaph-160 160 mg micronized capsule
n/a; importer: nelpa lifesciences, inc.; distributor: nelpa lifesciences, inc. - fenofibrate - micronized capsule - 160 mg
none 160 mg micronized capsule
nelpa lifesciences, inc; distributor: watsons personal care store (philippines), inc - fenofibrate - micronized capsule - 160 mg
none 160 mg micronized capsule
nelpa lifesciences, inc; distributor: ambitech biopharmaceuticals inc. - fenofibrate - micronized capsule - 160 mg
fenorix 200 mg micronized capsule
amb hk enterprises, inc.; distributor: amb hk enterprises, inc. - fenofibrate - micronized capsule - 200 mg